Google
 
Web globalrph.com
Home back calculators Drug Tables disclaimer IV Dilutions Medline news
 
 

Mediwire - home

Search  the Mediwire Library

  



Drug Discovery
Spotlight

A Cure for Multiple Sclerosis in Our Lifetime?

Practice guidelines for MS in the United States and Canada, where more than 500,000 people suffer from the disease, recommend disease-modifying agents for most patients, but at any given time only 20% are using the drugs. And less than three-fourths of total MS patients have even tried these drugs. Why is that?
  More>>
TOPIC AREAS
 
   
 
Search



Popular Search Terms
 
Featured Wire Releases What's this?
2-2-06 22:09 ET
Finding a Job in the Life Science and Healthcare Industry
Focus On: Business & Industry
Viewpoint

The Consequences of Limiting Stem Cell Research: Health and Economic Considerations

Testing theories through basic research has brought about tremendous advances too numerous to elaborate here. It also often comes with something we suspect most scientists would acknowledge as a constant by-product — the potential for opposition on what are stated as moral or religious grounds.
  More>>
Features

Facility Design and Expansion: Commissioning for Innovation

Once guiding principles are identified, designers can explore the most cost-effective methods for delivering a flexible, expandable site. A modern biotechnology facility resembles a living organism, constantly evolving and changing. As research programs change, so do the requirements for equipment, staff, and laboratory space.
  More>>


The Next Generation of Aseptic Processing Equipment

The industry has acknowledged only recently the significance of the contamination risk posed by humans. The authors assert that this realization, together with technological advances, will lead to the elimination of human intervention and, hence, improved sterility.
  More>>


Real-time PCR: Advancing RNA Interference and MicroRNA Studies

In recent years, researchers have made great strides toward understanding the role of endogenous small RNAs (miRNAs) in gene regulation and harnessing the power of exogenous small RNAs (siRNAs and shRNAs) as laboratory tools to manipulate messenger RNA (mRNA) levels. As the field has evolved, methods to identify, quantify and regulate these RNAs also have evolved. Now, a new miRNA assay that employs stem-loop primers allows researchers to easily and effectively assess small RNAs and greatly enhances the power of quantitative real-time PCR for small RNA studies.
  More>>


Immobilization of Oligonucleotides on a Silicon Surface

A new method for affixing DNA oligonucleotides to silicon surfaces increases signal intensity 20-fold compared to glass, enabling a silicon field-effect electrolyte-insulator-semiconductor (EIS) sensor that directly detects DNA hybridization.
  More>>
Wire Releases What's this?
November 2007
 
11-6-07 17:32 ET

New Physician Resource for Practice Management, Clinical Decision Support and Patient Care

March 2006
 
3-23-06 8:52 ET

Skyscape Launches Harriet Lane Handbook With Exclusive New Tools For Point of Care Decision-Support -- Featured at NAPNAP, booth #1213 --

3-13-06 11:13 ET
CME² Launches Seizure Disorders in the Elderly: Recognition, Diagnosis, and Treatment CME/CE Program

February 2006
 
2-2-06 22:09 ET

Finding a Job in the Life Science and Healthcare Industry

December 2005
 
12-21-05 15:03 ET

Innovative Healthcare Solutions Obtains National Distribution Rights for Breakthrough Technology to Administer IDD Therapy®

12-21-05 14:54 ET
New CME Activity Launched Online: “Current Therapeutic Options for Chronic Low Back Pain: A Focus on Nonsurgical Approaches”
More Wire Releases
Industry Roundup

FDA Approves Treatment for Smallpox Vaccination Side Effects

 


Nanoparticle Synthesis Process Facilitates Chiral Separations

 
A new resource for time-starved physicians and healthcare professionals
Modern Medicine - Click Here


Privacy Policy Disclaimer Copyright Editorial Policy Sponsorship Policy All Topics
   Powered by Mediwire
 
 
Contact . Privacy PolicyDisclaimer

Copyright  © 2005 GlobalRPh Inc.